Navigation Links
Singapore research organisations team up to advance drug discovery using brain tumor stem cells
Date:2/17/2009

ties for exchanging ideas and synergising efforts, more effective and less invasive cancer treatment is now one step closer to becoming a reality.

Dr. Jonathon D. Sedgwick, LSCDD Managing Director and Chief Scientific Officer, said that "discovering new, breakthrough medicines through translational and clinical research requires intensive collaborations amongst partners. This research collaboration with clinicians and scientists from NNI and SICS will bring together different expertise and resources. This fits well with Lilly's new collaborative model known as the Fully Integrated Pharmaceutical Network (FIPNet) model, and will enhance and accelerate Lilly's ability to find 'Answers That Matter'."

Dr. Judith Swain, SICS Executive Director, said that "this collaboration is aligned with our focus on disease-oriented clinical and translational research. The family of clinician scientists here at SICS is well positioned to perform critical work at the border between basic and clinical research. We look forward to working closely with LSCDD and NNI to develop cutting-edge approaches for novel drug development."

"NNI's research aims to improve treatment and discover cures for neurological disease. This collaboration will enable all parties to benefit from the exchange of multidisciplinary expertise and will expedite the translation of research findings into clinical practice," said Prof. Lee Wei Ling, Executive Director of NNI.


'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Singapore National Science and Technology Awards
2. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
3. Rare cancer-causing syndrome found, for the first time, in Singapore
4. Ludwig Institute for Cancer Research to set up its first Asian branch in Singapore
5. Singapores BIOPOLIS and FUSIONOPOLIS on stage in Boston this week
6. Singapore opens Fusionopolis, its second major R&D hub in 5 years
7. Singapore research team first place in Brain-Computer Interface contest
8. NTU undergrad is first Singapore champion of an internationally acclaimed engineering competition
9. Singapore-US scientists first to develop revolutionary microchip that uses 30 times less energy
10. Research shows skeleton to be endocrine organ
11. Newly created cancer stem cells could aid breast cancer research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ain chemical with an unwieldy name: 4-hydroxybutyr...ed as a date-rape drug. , Now, a team of Ohio a...by which 4-HB is metabolized by the body. "This is...ibson, professor and chair of biological sciences ...of the research team. "It may provide new clues o...
(Date:11/19/2009)... many countries of the world. It is widely used fo...aterials. It also is considered an exemplar plant ...ution, and genome architecture. The authors of the...d the first description of the B73 maize genome to...netics and plant biology. The ten papers consider ...
(Date:11/19/2009)... 19 BIO-key Internationa...reless public safety and finger-based biometric id... Shareholder Meeting held today was adjourned with...t present. ,, (Logo: http://www.newscom.com/cg...ressive 99.3% of the 35 million votes cast voted i...
Breaking Biology News(10 mins):Researchers begin to decipher metabolism of sexual assault drug 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Photos 3A New Yoplait 28R 29 YoPlus 28TM 29 Light A Delicious Way to Regulate Digestive Health With Fewer Calories 57506 1Photos 3A New Yoplait 28R 29 YoPlus 28TM 29 Light A Delicious Way to Regulate Digestive Health With Fewer Calories 57506 2Photos 3A New Yoplait 28R 29 YoPlus 28TM 29 Light A Delicious Way to Regulate Digestive Health With Fewer Calories 57506 3Clinical Trials Move to Emerging Regions Heighten Need for Local Risk Consulting 3A Aon Global Risk Map 14121 1Clinical Trials Move to Emerging Regions Heighten Need for Local Risk Consulting 3A Aon Global Risk Map 14121 2Clinical Trials Move to Emerging Regions Heighten Need for Local Risk Consulting 3A Aon Global Risk Map 14121 3Clinical Trials Move to Emerging Regions Heighten Need for Local Risk Consulting 3A Aon Global Risk Map 14121 4Clinical Trials Move to Emerging Regions Heighten Need for Local Risk Consulting 3A Aon Global Risk Map 14121 5Damon Runyon 5K Run Walk at Yankee Stadium to Benefit Cancer Research 57502 1Damon Runyon 5K Run Walk at Yankee Stadium to Benefit Cancer Research 57502 2Damon Runyon 5K Run Walk at Yankee Stadium to Benefit Cancer Research 57502 3Damon Runyon 5K Run Walk at Yankee Stadium to Benefit Cancer Research 57502 4
...rves have been jangled by a baby,s howl or who hav...n knows, nature has evolved sensory systems to be ...ion in neurobiology is how neurons tune the streng...to such inputs. , Neuronal circuitry consists of a...ng bursts of neurotransmitters at targets on recei...
...scovered that a group of important immune system c...tish superspy James Bond: the cells receive a "lic...t attacks on enemies. , This licensing process app...ll erroneously direct their firepower at the body,...ton University School of Medicine in St. Louis. Th...
...r, at least not the size of the eyespots on a male...r potential mates. , Instead, females are attract...lectivity of the pupils, the white circles at the ... University at Buffalo biologists. , The research,... of the Royal Society B: Biological Sciences, over...
Other Biology News:Grasshopper love songs give insight into sensory tuning 2'License to kill' enables powerful immune attack cells in mice 2'License to kill' enables powerful immune attack cells in mice 3Female butterflies go for sparkle -- not size -- when choosing to mate 2Female butterflies go for sparkle -- not size -- when choosing to mate 3
(Date:11/20/2009)...E, Nov. 20 Dendreon Corp...U.S. Food and Drug Administration (FDA) provided w...Biologics License Application (BLA) for PROVENGE&#...DA has assigned a Prescription Drug User Fee Act (...respond to Dendreon,s amended BLA. Dendreon is se...
(Date:11/20/2009)... METTLER TOLEDO recently announced that a f...imization Using At-Line Particle Characterization&... this webinar, the application of in situ particle...n space and optimize a series of roller compaction... roller compaction forces. , ...
(Date:11/19/2009)..., Nov. 19 Omeros Corpora...nancial results for the third quarter ended Septem... 30, 2009, Omeros reported a net loss of $3.9 mill... of $7.4 million, or $2.54 per share, for the same...er 30, 2009, the Company reported a net loss of $1...
(Date:11/19/2009)...A, Md., Nov. 19 Spherix ...technology for diabetes therapy, and a provider of...ood, supplement, biotechnology and pharmaceutical ...s Annual Meeting of Shareholders. ,, At the mee...: SPEX ) elected the following members to the Boa...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...heduled for Thursday, March 27TH AT 5 PM ... 20 ImaRx Therapeutics,Inc. (Nasdaq: IMRX ) toda...ast and conference call on Thursday, March 27, 200...d fourth quarter 2007 financial results., The liv...e website at, http://www.imarx.com and will be ar...
...irstCall/ - Chromos Molecular,Systems Inc. ("Chrom...tered,into a secured, convertible debenture agreem...re to be used to fund expenses associated with the...ocuments and maintaining,the integrity of the rema...erest, at 12% per annum, are due and payable on Ju...
...armAthene,s Status as a Premie...panded Biodefense Pipeline ANNAPOLIS, Md., and TE... biodefense company,specializing in the developmen... against biological and chemical threats, and Avec...iopharmaceuticals, announced,today that the compan...
Other Biology Technology:ImaRx to Report Corporate Updates and 4Q07 Financial Results 2Chromos enters into loan and lending arrangements 2PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 2PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 3PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 4PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 5PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 6
Oligonucleotides from Thermo Scientific
Mouse Anti-Human QPCT Monoclonal Antibody, Unconjugated, Clone 4E11 from Novus Biologicals
LS Columns from Miltenyi Biotec
Corning ultragaps Coated Slides,Bar-Coded from Sigma-Aldrich
Biology Products: